logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 4
  • 1
    Lewis, Gary Stephen
    Born in February 1960
    Individual (11 offsprings)
    Officer
    2013-04-30 ~ now
    OF - Director → CIF 0
    Mr Gary Stephen Lewis
    Born in February 1960
    Individual (11 offsprings)
    Person with significant control
    2016-05-01 ~ now
    PE - Has significant influence or control as a member of a firmCIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 2
    Lewis, Henry Thomas John
    Born in April 1988
    Individual (4 offsprings)
    Officer
    2019-08-01 ~ now
    OF - Director → CIF 0
  • 3
    Lewis, Thomas William
    Born in December 1989
    Individual (4 offsprings)
    Officer
    2019-08-01 ~ now
    OF - Director → CIF 0
  • 4
    Lewis, Carmen
    Born in January 1965
    Individual (8 offsprings)
    Officer
    2013-04-30 ~ now
    OF - Director → CIF 0
    Mrs Carmen Lewis
    Born in January 1965
    Individual (8 offsprings)
    Person with significant control
    2025-11-21 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Has significant influence or control as a member of a firmCIF 0
parent relation
Company in focus

A1 PHARMACEUTICALS HOLDINGS LIMITED

Period: 2013-04-30 ~ now
Company number: 08511438
Registered name
A1 PHARMACEUTICALS HOLDINGS LIMITED - now
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
21100 - Manufacture Of Basic Pharmaceutical Products
Brief company account
Average Number of Employees
42024-05-01 ~ 2025-04-30
42023-05-01 ~ 2024-04-30
Fixed Assets - Investments
49,000 GBP2025-04-30
49,000 GBP2024-04-30
Fixed Assets
49,000 GBP2025-04-30
49,000 GBP2024-04-30
Debtors
Current
15,053,000 GBP2025-04-30
14,114,210 GBP2024-04-30
Current Assets
15,053,000 GBP2025-04-30
14,114,210 GBP2024-04-30
Net Current Assets/Liabilities
15,053,000 GBP2025-04-30
12,553,000 GBP2024-04-30
Total Assets Less Current Liabilities
15,102,000 GBP2025-04-30
12,602,000 GBP2024-04-30
Equity
Called up share capital
1,000 GBP2025-04-30
1,000 GBP2024-04-30
1,000 GBP2023-05-01
Capital redemption reserve
49,000 GBP2025-04-30
49,000 GBP2024-04-30
49,000 GBP2023-05-01
Retained earnings (accumulated losses)
15,052,000 GBP2025-04-30
12,552,000 GBP2024-04-30
11,052,000 GBP2023-05-01
Equity
15,102,000 GBP2025-04-30
12,602,000 GBP2024-04-30
11,102,000 GBP2023-05-01
Profit/Loss
Retained earnings (accumulated losses)
2,661,807 GBP2024-05-01 ~ 2025-04-30
1,620,140 GBP2023-05-01 ~ 2024-04-30
Profit/Loss
2,661,807 GBP2024-05-01 ~ 2025-04-30
1,620,140 GBP2023-05-01 ~ 2024-04-30
Dividends Paid
Retained earnings (accumulated losses)
-161,807 GBP2024-05-01 ~ 2025-04-30
-120,140 GBP2023-05-01 ~ 2024-04-30
Dividends Paid
-161,807 GBP2024-05-01 ~ 2025-04-30
-120,140 GBP2023-05-01 ~ 2024-04-30
Amounts Owed by Group Undertakings
Current
3,169,131 GBP2025-04-30
Other Debtors
Current
11,883,869 GBP2025-04-30
14,114,210 GBP2024-04-30
Amounts owed to group undertakings
Current
1,561,210 GBP2024-04-30
Creditors
Current
1,561,210 GBP2024-04-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
900 shares2025-04-30
900 shares2024-04-30
Par Value of Share
Class 1 ordinary share
1.002024-05-01 ~ 2025-04-30
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
50 shares2025-04-30
50 shares2024-04-30
Par Value of Share
Class 2 ordinary share
1.002024-05-01 ~ 2025-04-30
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
50 shares2025-04-30
50 shares2024-04-30
Par Value of Share
Class 3 ordinary share
1.002024-05-01 ~ 2025-04-30

Related profiles found in government register
  • A1 PHARMACEUTICALS HOLDINGS LIMITED
    Info
    Registered number 08511438
    Unit 20 & 21 Easter Industrial Park, Ferry Lane South, Rainham, Essex RM13 9BP
    PRIVATE LIMITED COMPANY incorporated on 2013-04-30 (13 years). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-03-23
    CIF 0
  • A1 PHARMACEUTICALS HOLDING LIMITED
    S
    Registered number 8511438
    Unit 20-21, Ferry Lane, Rainham, England, RM13 9BP
    Private Limited Company in England And Wales, England
    CIF 1
child relation
Offspring entities and appointments 1
  • 1
    A1 PHARMACEUTICALS PUBLIC LIMITED COMPANY
    - now 02690345
    MAYLAKE LIMITED - 1995-05-17
    Unit 20 & 21 Easter Industrial, Park, Ferry Lane South, Rainham, Essex
    Active Corporate (9 parents)
    Person with significant control
    2025-12-12 ~ now
    CIF 1 - Ownership of shares – 75% or more OE
    CIF 1 - Ownership of voting rights - 75% or more OE
    CIF 1 - Right to appoint or remove directors OE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.